Document Type


Publication Date



This article has been peer reviewed. It is the authors' final version prior to publication in Current Rheumatology Reviews

Volume 6, Issue 4, November 2010, Pages 283-294.

The published version is available at DOI: 10.2174/157339710793205611. Copyright © Bentham Science Publishers Ltd.


The most severe clinical and pathologic manifestations of systemic sclerosis (SSc) are the result of a fibrotic process characterized by the excessive and often progressive deposition of collagen and other connective tissue macromolecules in skin and numerous internal organs. The mechanisms involved in the initiation and progression of the remarkable fibrotic process in SSc remain largely unknown. Extensive recent studies have indicated that a variety of polypeptide growth factors play a crucial role in this process. The most commonly implicated growth factors include transforming growth factor beta (TGF-β), connective tissue growth factor (CTGF), platelet derived growth factor (PDGF), and vascular endothelial growth factor (VEGF). Here, the experimental evidence supporting the participation of various growth factors in the pathogenesis of the fibrotic process in SSc and the molecular mechanisms involved will be reviewed.

PubMed ID


Included in

Rheumatology Commons